---
layout: post
title: "Prospective Grant of Exclusive, Inter-Institutional Agreement-Institution Lead: Generation of Antigen-Specific T and B Cells Using Engineered Commensals"
date: 2026-02-04 21:48:42 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-12381
original_published: 2025-07-02 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of Exclusive, Inter-Institutional Agreement-Institution Lead: Generation of Antigen-Specific T and B Cells Using Engineered Commensals

**Published:** February 04, 2026 21:48 UTC
**Source:** Federal Register
**Original Published:** July 02, 2025 00:00 UTC
**Document Number:** 2025-12381

## Summary

The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive, Inter- Institutional Agreement-Institution Lead to CZ Biohub SF, LLC ("CZB"), located in San Francisco, California, in its rights to the technologies and patent applications listed in the Supplementary Information section of this notice.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/07/02/2025-12381/prospective-grant-of-exclusive-inter-institutional-agreement-institution-lead-generation-of)
- API: https://www.federalregister.gov/api/v1/documents/2025-12381

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
